Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Brain Imaging01:14

Brain Imaging

927
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans),  magnetic resonance imaging (MRI),  functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
927

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiparametric MRI Model Predicts Parenchymal Hematoma in Acute Ischemic Stroke After Reperfusion.

AJNR. American journal of neuroradiology·2026
Same author

Dysfunctional large-scale networks linking PTSD and cognitive impairment.

Journal of psychiatric research·2026
Same author

Relationship between new-onset falls and neuroimaging markers of Alzheimer's disease in the UK Biobank.

Journal of Alzheimer's disease : JAD·2026
Same author

Evaluation for Potential Inequities in Efficacy and Patient Outcomes Following Implementation of a STAT Outpatient Neuroimaging Pathway for Evaluation of Patients with Optic Disc Swelling.

Neuro-ophthalmology (Aeolus Press)·2026
Same author

Disproportionately elevated sulcal index (DESI): An automatically driven index representing disproportionate subarachnoid space enlargement in brain MRI scans.

Brain research bulletin·2026
Same author

Altered resting-state functional connectivity in bipolar disorder: a systematic review.

Brain imaging and behavior·2026

Related Experiment Video

Updated: Mar 29, 2026

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

1.1K

ACR-ASNR Practice Parameter for Brain PET/CT Imaging Dementia.

Kirk A Frey1, Martin A Lodge, Carolyn Cidis Meltzer

  • 1From the *Department of Nuclear Medicine, University of Michigan Medical Center, Ann Arbor, MI; †Outpatient Center, Johns Hopkins University, Baltimore, MD; ‡Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, GA; §Eka Medical Center, Jakarta, Indonesia; ∥UNC Department of Radiology, Chapel Hill, NC; ¶Neuroradiology Section, Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA; **Division of Neuroradiology, Department of Radiology, Duke University Medical Center, Durham, NC; ††Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine; and ‡‡Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins Medical Institution, Baltimore, MD.

Clinical Nuclear Medicine
|December 10, 2015
PubMed
Summary

This practice parameter outlines the use of FDG and amyloid PET/CT scans for diagnosing cognitive decline. It addresses indications and personnel qualifications for these crucial neuroimaging techniques in dementia evaluation.

More Related Videos

A Dual Tracer PET-MRI Protocol for the Quantitative Measure of Regional Brain Energy Substrates Uptake in the Rat
15:10

A Dual Tracer PET-MRI Protocol for the Quantitative Measure of Regional Brain Energy Substrates Uptake in the Rat

Published on: December 28, 2013

7.5K
PET Imaging of Neuroinflammation Using [11C]DPA-713 in a Mouse Model of Ischemic Stroke
12:01

PET Imaging of Neuroinflammation Using [11C]DPA-713 in a Mouse Model of Ischemic Stroke

Published on: June 14, 2018

13.3K

Related Experiment Videos

Last Updated: Mar 29, 2026

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

1.1K
A Dual Tracer PET-MRI Protocol for the Quantitative Measure of Regional Brain Energy Substrates Uptake in the Rat
15:10

A Dual Tracer PET-MRI Protocol for the Quantitative Measure of Regional Brain Energy Substrates Uptake in the Rat

Published on: December 28, 2013

7.5K
PET Imaging of Neuroinflammation Using [11C]DPA-713 in a Mouse Model of Ischemic Stroke
12:01

PET Imaging of Neuroinflammation Using [11C]DPA-713 in a Mouse Model of Ischemic Stroke

Published on: June 14, 2018

13.3K

Area of Science:

  • Neurology and Radiology
  • Neuroimaging Techniques
  • Cognitive Decline Diagnostics

Background:

  • Dementia affects millions globally, with numbers projected to rise significantly.
  • Four primary neurodegenerative causes of dementia include Alzheimer disease (AD), vascular dementia, frontotemporal dementia (FTD), and dementia with Lewy bodies (DLB).
  • Alzheimer disease is the most prevalent form, comprising 60%-80% of all dementia cases.

Purpose of the Study:

  • To provide a practice parameter for the use of FDG and amyloid PET or PET/CT in patients experiencing cognitive decline.
  • To establish guidelines for indications and personnel qualifications for these neuroimaging modalities.

Main Methods:

  • Development of a collaborative practice parameter by the American College of Radiology (ACR) and the American Society of Neuroradiology (ASNR).
  • Review of current indications for FDG and amyloid brain PET/CT.
  • Definition of qualifications for personnel administering and interpreting these scans.

Main Results:

  • The practice parameter details specific indications for utilizing FDG and amyloid PET/CT in the diagnostic workup of cognitive decline.
  • Guidelines are provided regarding the necessary qualifications for healthcare professionals involved in these procedures.

Conclusions:

  • This parameter serves as a comprehensive guide for the appropriate application of FDG and amyloid PET/CT in evaluating patients with cognitive decline.
  • Standardized indications and personnel qualifications aim to improve diagnostic accuracy and patient care in dementia.